Literature DB >> 3780671

Beta zero thalassemia caused by a base substitution that creates an alternative splice acceptor site in an intron.

J E Metherall, F S Collins, J Pan, S M Weissman, B G Forget.   

Abstract

A thalassemic beta-globin gene cloned from a haplotype I chromosome contains a T to G transversion at position 116 of IVS1 which results in the generation of an abnormal alternative acceptor splice site. Transient expression studies revealed a 4-fold decrease in the amount of RNA produced with greater than 99% of it being abnormally spliced despite preservation of the normal acceptor splice site at position 130. These results suggest that the mutation at IVS1 position 116 results in beta zero thalassemia. A closely related mutation at position 110 of IVS1 also generates a novel acceptor site and results in a similar decrease in total mRNA produced, but approximately 20% of the mRNA produced is normally spliced and thus the phenotype is that of beta + thalassemia. These observations suggest that short range position effects may play a dramatic role in the choice of potential splice acceptor sites. We demonstrate the presence of abnormally spliced mRNA in reticulocytes of affected individuals and show the mutation at IVS1 position 116 segregating from the mutation at IVS1 position 110 in a three generation pedigree. The mutation results in the creation of a MaeI restriction site, as do a number of other thalassemic mutations, and we demonstrate some difficulties that may arise in the differential diagnosis of these mutations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780671      PMCID: PMC1167152          DOI: 10.1002/j.1460-2075.1986.tb04534.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  Identification of a beta-thalassemia mutation associated with a novel haplotype of RFLPs.

Authors:  G F Atweh; B G Forget
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

5.  RNA polymerase nascent product analysis.

Authors:  M Takanami
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Are snRNPs involved in splicing?

Authors:  M R Lerner; J A Boyle; S M Mount; S L Wolin; J A Steitz
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  BKV splice sequences based on analysis of preferred donor and acceptor sites.

Authors:  I Seif; G Khoury; R Dhar
Journal:  Nucleic Acids Res       Date:  1979-07-25       Impact factor: 16.971

9.  Mild thalassemia: the result of interactions of alpha and beta thalassemia genes.

Authors:  Y W Kan; D G Nathan
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  12 in total

1.  Increased rate of base substitution in a hamster mutator strain obtained during serial selection for gene amplification.

Authors:  M A Caligo; W Armstrong; B J Rossiter; M Meuth
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Prenatal and post-natal screening of β-thalassemia and hemoglobin E genes in Thailand using denaturing high performance liquid chromatography.

Authors:  Thanet Prajantasen; Supan Fucharoen; Goonnapa Fucharoen; Nirut Siriratmanawong; Charnchai Pinmuang-Ngam
Journal:  Mol Biol Rep       Date:  2012-12-26       Impact factor: 2.316

3.  Analyses of linked beta-globin genes suggest that nondeletion forms of hereditary persistence of fetal hemoglobin are bona fide switching mutants.

Authors:  J E Metherall; F P Gillespie; B G Forget
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

4.  Nonsense mutations in the human beta-globin gene affect mRNA metabolism.

Authors:  S J Baserga; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Structure-guided U2AF65 variant improves recognition and splicing of a defective pre-mRNA.

Authors:  Anant A Agrawal; Krystle J McLaughlin; Jermaine L Jenkins; Clara L Kielkopf
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 6.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

7.  Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns.

Authors:  C W Smith; T T Chu; B Nadal-Ginard
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Differential accumulation of four phaseolin glycoforms in transgenic tobacco.

Authors:  M M Bustos; F A Kalkan; K A VandenBosch; T C Hall
Journal:  Plant Mol Biol       Date:  1991-03       Impact factor: 4.076

9.  Splicing in Caenorhabditis elegans does not require an AG at the 3' splice acceptor site.

Authors:  R V Aroian; A D Levy; M Koga; Y Ohshima; J M Kramer; P W Sternberg
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

Review 10.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.